VanEck Associates’s ChampionX CHX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-23,855
Closed -$584K 1425
2025
Q3
$584K Sell
23,855
-1,887,763
-99% -$49.9M ﹤0.01% 1163
2025
Q2
$47.5M Sell
1,911,618
-138,687
-7% -$3.49M 0.05% 214
2025
Q1
$61.1M Sell
2,050,305
-589,047
-22% -$17.2M 0.08% 170
2024
Q4
$71.8M Buy
2,639,352
+9,056
+0.3% +$269K 0.09% 147
2024
Q3
$78M Sell
2,630,296
-173,422
-6% -$5.48M 0.1% 139
2024
Q2
$93.1M Sell
2,803,718
-120,284
-4% -$4.1M 0.13% 123
2024
Q1
$105M Sell
2,924,002
-505,570
-15% -$15.1M 0.16% 117
2023
Q4
$100M Sell
3,429,572
-509,408
-13% -$15.8M 0.18% 115
2023
Q3
$140M Sell
3,938,980
-563,976
-13% -$20M 0.31% 93
2023
Q2
$140M Sell
4,502,956
-348,565
-7% -$9.6M 0.31% 87
2023
Q1
$132M Buy
4,851,521
+214,590
+5% +$6.41M 0.3% 84
2022
Q4
$134M Sell
4,636,931
-609,895
-12% -$16.8M 0.35% 79
2022
Q3
$103M Sell
5,246,826
-1,896,201
-27% -$39.1M 0.31% 86
2022
Q2
$142M Sell
7,143,027
-730,473
-9% -$16.5M 0.38% 75
2022
Q1
$193M Buy
7,873,500
+2,065,566
+36% +$47.8M 0.4% 62
2021
Q4
$117M Sell
5,807,934
-687,738
-11% -$16.2M 0.27% 93
2021
Q3
$145M Sell
6,495,672
-217,242
-3% -$4.96M 0.37% 76
2021
Q2
$172M Buy
6,712,914
+4,117,726
+159% +$100M 0.41% 62
2021
Q1
$56.4M Buy
2,595,188
+95,500
+4% +$1.86M 0.15% 143
2020
Q4
$38.2M Buy
2,499,688
+377,169
+18% +$4.19M 0.11% 150
2020
Q3
$17M Sell
2,122,519
-46,585
-2% -$449K 0.05% 199
2020
Q2
$21.2M Buy
2,169,104
+484,408
+29% +$4.44M 0.07% 173
2020
Q1
$9.69M Buy
1,684,696
+531,670
+46% +$11M 0.05% 217
2019
Q4
$38.9M Buy
1,153,026
+118,905
+11% +$3.24M 0.15% 124
2019
Q3
$28M Sell
1,034,121
-18,551
-2% -$542K 0.13% 144
2019
Q2
$35.3M Buy
1,052,672
+143,398
+16% +$5.21M 0.17% 126
2019
Q1
$37.3M Sell
909,274
-570,254
-39% -$21.1M 0.18% 122
2018
Q4
$40.1M Buy
1,479,528
+597,451
+68% +$22M 0.2% 103
2018
Q3
$38.4M Buy
+882,077
New +$37M 0.19% 126

VanEck Associates's CHX Position: Q4 2025 in Review

VanEck Associates sold out of ChampionX (CHX) in Q4 2025, closing a stake of 23,855 shares — an estimated $584K sold.

VanEck Associates first reported a position in CHX in Q3 2018 and held it in 29 quarters. The position peaked at $193M in Q1 2022. 0 funds tracked by Wall St. Rank hold CHX as of Q4 2025.

  • VanEck Associates reported no remaining ChampionX position as of Q4 2025 after selling out during the quarter.
  • VanEck Associates sold 23,855 ChampionX shares in Q4 2025, an estimated $584K.
  • VanEck Associates first reported a position in ChampionX in Q3 2018 and held it in 29 quarters.
  • VanEck Associates's ChampionX position peaked at $193M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held ChampionX as of Q4 2025.

Based on VanEck Associates's 13F filing for Q4 2025, filed 13 Feb 2026.